Andrea Matucci

5.2k total citations · 1 hit paper
114 papers, 3.2k citations indexed

About

Andrea Matucci is a scholar working on Physiology, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Andrea Matucci has authored 114 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Physiology, 48 papers in Immunology and 26 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Andrea Matucci's work include Asthma and respiratory diseases (51 papers), Immunodeficiency and Autoimmune Disorders (30 papers) and Drug-Induced Adverse Reactions (24 papers). Andrea Matucci is often cited by papers focused on Asthma and respiratory diseases (51 papers), Immunodeficiency and Autoimmune Disorders (30 papers) and Drug-Induced Adverse Reactions (24 papers). Andrea Matucci collaborates with scholars based in Italy, Spain and United States. Andrea Matucci's co-authors include Alessandra Vultaggio, Enrico Maggi, Francesca Nencini, Paola Parronchi, Oliviero Rossi, Sergio Romagnani, Sara Pratesi, M Ricci, Francesco Annunziato and Ismail Kasujee and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Scientific Reports.

In The Last Decade

Andrea Matucci

111 papers receiving 3.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Eosinophils in Health and Disease: A State-of-the-Art Review

2021 164 citations Michael E. Wechsler, Ariel Munitz et al. Mayo Clinic Proceedings profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Andrea Matucci Italy	32	1.3k	1.1k	675	609	606	114	3.2k
Alessandra Vultaggio Italy	32	1.1k 0.9×	810 0.7×	512 0.8×	628 1.0×	464 0.8×	124	2.9k
Mary Ann Mascelli United States	33	1.8k 1.4×	507 0.5×	509 0.8×	220 0.4×	253 0.4×	64	4.1k
Moisés Labrador‐Horrillo Spain	30	609 0.5×	380 0.3×	1.2k 1.8×	685 1.1×	258 0.4×	123	3.0k
Allen Radin United States	24	1.3k 1.0×	2.3k 2.1×	1.1k 1.7×	2.2k 3.6×	624 1.0×	53	5.2k
Sinisa Savic United Kingdom	33	1.3k 1.0×	173 0.2×	649 1.0×	182 0.3×	379 0.6×	142	3.1k
Bruce K. Tan United States	43	1.3k 1.0×	2.7k 2.5×	257 0.4×	3.0k 4.9×	800 1.3×	180	7.3k
Paul Hasler Switzerland	27	2.0k 1.6×	308 0.3×	451 0.7×	199 0.3×	338 0.6×	66	3.2k
W F Owen United States	19	1.0k 0.8×	1.2k 1.1×	744 1.1×	447 0.7×	400 0.7×	22	2.6k
Phillip E. Korenblat United States	19	958 0.8×	2.0k 1.8×	157 0.2×	669 1.1×	1.3k 2.2×	44	2.7k
Naotake Tsuboi Japan	28	1.3k 1.0×	261 0.2×	354 0.5×	248 0.4×	457 0.8×	114	3.3k

Countries citing papers authored by Andrea Matucci

Since Specialization

Citations

This map shows the geographic impact of Andrea Matucci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrea Matucci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrea Matucci more than expected).

Fields of papers citing papers by Andrea Matucci

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrea Matucci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrea Matucci. The network helps show where Andrea Matucci may publish in the future.

Co-authorship network of co-authors of Andrea Matucci

This figure shows the co-authorship network connecting the top 25 collaborators of Andrea Matucci. A scholar is included among the top collaborators of Andrea Matucci based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrea Matucci. Andrea Matucci is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Vivarelli, Emanuele, Manlio Milanese, Giandomenico Maggiore, et al.. (2025). Asthma Phenotype Can Be Influenced by Recurrent Respiratory Infections in Patients with Primary Antibody Deficiency: The Impact of Ig Therapy. Respiration. 104(7). 457–465.

Bagnasco, Diego, Alvise Berti, Giorgio Walter Canonica, et al.. (2024). The Role of IL-5 in Type 2 Inflammatory Diseases. European Medical Journal. 62–72. 2 indexed citations

Matucci, Andrea, et al.. (2024). Efficacy and safety of dupilumab in the treatment of CRSwNP in the real-life setting: a review of the literature. European Archives of Oto-Rhino-Laryngology. 281(10). 5023–5031. 11 indexed citations

Matucci, Andrea, et al.. (2023). Effectiveness of dupilumab versus endoscopic sinus surgery for the treatment of type-2 chronic rhinosinusitis with nasal polyps: a preliminary report. European Archives of Oto-Rhino-Laryngology. 281(3). 1317–1324. 14 indexed citations

Liu, Mark C., Diego Bagnasco, Andrea Matucci, et al.. (2023). Mepolizumab in Patients With Severe Asthma and Comorbidities: 1-Year REALITI-A Analysis. The Journal of Allergy and Clinical Immunology In Practice. 11(12). 3650–3661.e3. 19 indexed citations

Banini, Marco, Viola Salvestrini, Alessandra Vultaggio, et al.. (2023). Desensitization Protocol for Cemiplimab-Related Infusion Reaction in Cutaneous Squamous Cell Carcinoma: A Case Report and Literature Review. Current Oncology. 30(7). 6699–6707. 2 indexed citations

Chupp, Geoffrey, Isam Alobid, Njira Lugogo, et al.. (2023). Mepolizumab Reduces Systemic Corticosteroid Use in Chronic Rhinosinusitis With Nasal Polyps. The Journal of Allergy and Clinical Immunology In Practice. 11(11). 3504–3512.e2. 11 indexed citations

Wechsler, Michael E., Ariel Munitz, Steven J. Ackerman, et al.. (2021). Eosinophils in Health and Disease: A State-of-the-Art Review. Mayo Clinic Proceedings. 96(10). 2694–2707. 164 indexed citations breakdown →

Vultaggio, Alessandra, Francesca Nencini, Elena Silvestri, et al.. (2021). Drug-specific Treg cells are induced during desensitization procedure for rituximab and tocilizumab in patients with anaphylaxis. Scientific Reports. 11(1). 12558–12558. 9 indexed citations

10.

Demoly, Pascal, Andrea Matucci, Oliviero Rossi, & Carmen Vidal. (2020). The disease burden in patients with respiratory allergies induced by house dust mites: a year-long observational survey in three European countries. Clinical and Translational Allergy. 10(1). 27–27. 8 indexed citations

11.

Canessa, Clementina, Vera Gallo, Claudio Pignata, et al.. (2019). Subcutaneous Immunoglobulin Twenty Percent Every Two Weeks in Pediatric Patients with Primary Immunodeficiencies: Subcohort Analysis of the IBIS Study. Pediatric Allergy Immunology and Pulmonology. 32(2). 70–75. 3 indexed citations

12.

Matucci, Andrea, Enrico Maggi, & Alessandra Vultaggio. (2019). Eosinophils, the IL-5/IL-5Rα axis, and the biologic effects of benralizumab in severe asthma. Respiratory Medicine. 160. 105819–105819. 44 indexed citations

13.

Viti, Raffaella, Andrea Marcellusi, Alessandro Capone, et al.. (2018). Direct and Indirect Costs of Immunoglobulin Replacement Therapy in Patients with Common Variable Immunodeficiency (CVID) and X-Linked Agammaglobulinemia (XLA) in Italy. Clinical Drug Investigation. 38(10). 955–965. 4 indexed citations

14.

Matucci, Andrea, Alessandra Vultaggio, & Romano Danesi. (2018). The use of intravenous versus subcutaneous monoclonal antibodies in the treatment of severe asthma: a review. Respiratory Research. 19(1). 154–154. 37 indexed citations

15.

Sposato, Bruno, Manlio Milanese, Simonetta Masieri, et al.. (2018). Factors reducing omalizumab response in severe asthma. European Journal of Internal Medicine. 52. 78–85. 49 indexed citations

16.

Minozzi, Silvia, Stefanos Bonovas, Theodore Lytras, et al.. (2016). Risk of malignancies using anti-TNF agents in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. Expert Opinion on Drug Safety. 15. 11–34. 68 indexed citations

17.

Vultaggio, Alessandra, Andrea Matucci, Francesca Nencini, et al.. (2009). Anti‐infliximab IgE and non‐IgE antibodies and induction of infusion‐related severe anaphylactic reactions. Allergy. 65(5). 657–661. 183 indexed citations

18.

Cosmi, Lorenzo, Laura Maggi, Veronica Santarlasci, et al.. (2006). Detection by Flow Cytometry of ESAT-6- and PPD-Specific Circulating CD4+ T Lymphocytes as a Diagnostic Tool for Tuberculosis. International Archives of Allergy and Immunology. 143(1). 1–9. 25 indexed citations

19.

Brugnolo, Francesca, Francesco Annunziato, Salvatore Sampognaro, et al.. (1999). Highly Th2-skewed cytokine profile of beta-lactam-specific T cells from nonatopic subjects with adverse drug reactions.. PubMed. 163(2). 1053–9. 62 indexed citations

20.

Ricci, M, Andrea Matucci, & Oliviero Rossi. (1993). [Current advances in various aspects of chronic obstructive bronchopneumopathy and in the pathogenesis of bronchial asthma].. PubMed. 8(2). 95–103.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact